Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as potentially alleviate some of the drug's common side effects.

Adults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside moderate calorie restriction achieve much higher ...

The reason is unclear but experts say those with the condition often engage in unhealthy habits and struggle to access health care.

The focus on how BMI should be used may have overshadowed an equally, if not more important, matter proposed in a new report.

Overweight scores continue from 25-30. And over 30 is obese. Quetelet merely used this early calculation as a descriptor. He did not make any medical proclamations. The Quetelet Index became ...

If you’ve been diagnosed with major depressive disorder, seasonal affective depression or any other type of depression, your ...

The diabetes startup is prescribing GLP-1 drugs for weight loss to help employers manage costs. Its CEO says it's nearing ...

Hemak, president and CEO of the Wright Centers for Community Health and Graduate Medical Education, was named one of the 100 most powerful and influential female leaders in ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...